Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-20T01:08:54.250Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlling the Clonal Spread of Pseudomonas aeruginosa Infection

Published online by Cambridge University Press:  02 January 2015

Graziella H. Pereira ,
Anna S. Levin ,
Helenice Bosco Oliveira  and
Maria Luiza Moretti
Graziella H. Pereira*
Affiliation:
Institute of Infectious Diseases Emilio Ribas, Campinas, Brazil
Anna S. Levin
Affiliation:
Department of Infectious Diseases, Faculdade de Medicina, University of São Paulo, Campinas, Brazil
Helenice Bosco Oliveira
Affiliation:
Department of Epidemiology, Faculty of Medical Sciences, Campinas, Brazil
Maria Luiza Moretti
Affiliation:
Department of Internal Medicine, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil
*
Av. Jandira 79, Apt. 231, São Paulo-SP 04080-04000, Brazil (ghpereiral@terra.com.br)
Get access Rights & Permissions [Opens in a new window]

Abstract

To evaluate nosocomial infections due to imipenem-resistant and imipenem-susceptible Pseudomonas aeruginosa, a case-control study that included genotyping was performed. Hospitalization for more than 15 days was independently associated with infection with an imipenem-resistant organism. Sixty-seven percent of the imipenem-resistant isolates analyzed and 23% of the imipenem-susceptible isolates analyzed belonged to a single clone. Intervention led to a decrease in the number of infections due to imipenem-resistant and imipenem-susceptible P. aeruginosa.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 6 , June 2008 , pp. 549 - 552
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance (NNIS) System Report: data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;3:481–498.Google Scholar
2.Kiffer, C, Hsiung, A, Oplustil, C, et al. MYSTIC Brazil Group. Antimicrobial susceptibility of gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003. Braz J Infect Dis 2005;9:216–224.CrossRefGoogle ScholarPubMed
3.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
4.NCCLS. Performance standards for antimicrobial susceptibility testing. NCCLS document. Wayne, PA: NCCLS, 2000:M7–A5.Google Scholar
5.Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.Google Scholar
6.Arruda, EA, Marinho, IS, Boulos, M, et al. Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 1999;20:620–623.Google Scholar
7.D'Agata, EMC, Thayer, V, Schaffner, W. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000;21:588–591.CrossRefGoogle ScholarPubMed
8.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35:S165–S193.CrossRefGoogle ScholarPubMed